# Exela Pharma Sciences LLC – FDA Inspection, Jan 20, 2012

Source: https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/c344f0a7-008a-42be-a7fd-eb11e680bd10
Source feed: FDA_Inspections

> FDA inspection 766906 of Exela Pharma Sciences LLC, January 20, 2012. Classification: No Action Indicated (NAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 766906
- Company Name: Exela Pharma Sciences LLC
- Inspection Date: 2012-01-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1256957 - 2024-11-15](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/c49bbdca-1ca9-482e-af5f-49658d2feb1c)
- [FDA Inspection 1096634 - 2019-07-18](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/158d466d-f3a8-44b8-83e0-cf8497d372f6)
- [FDA Inspection 1084304 - 2019-03-29](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/4905f687-c73c-4645-b475-2579c09ea06e)
- FDA Inspection 1081405 - 2018-12-19
- [FDA Inspection 1067755 - 2018-09-11](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/04fb85de-d9ad-4cdf-b407-5e409c65b64c)

Company: https://www.keypedia.com/companies/exela-pharma-sciences-llc/4e6f3b32-adeb-41f4-b9dd-a8e7784569b3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c